Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1043-1051

  Chelbi Alix, Mounira K ^a   Quignon, Frédérique ^a   Pelicano, Luis ^a   Koken, Marcel H M ^a   De Thé, Hugues ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ANTIVIRAL ACTIVITY; ARTICLE; ENCEPHALOMYOCARDITIS VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION RESISTANCE; INFLUENZA VIRUS A; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS;

EID: 0031907092     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1043-1051.1998     Document Type: Article

References (47)

1. Alber, D., and P. Staeheli. 1996. Partial inhibition of vesicular stomatitis virus by the interferon-induced human 9-27 protein. J. Interferon Cytokine Res. 16:375-380.
2. Arnheiter, H., and E. Meier. 1990. Mx proteins: antiviral proteins by chance or by necessity. New Biol. 2:851-857.
3. Banerjee, A. K., and D. Chattopadhyay. 1990. Structure and function of the RNA polymerase of vesicular stomatitis virus. Adv. virus Res. 38:99-124.
4. Barlow, P. N., B. Luisi, A. Milner, M. Elliott, and R. Everett. 1994. Structure of the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc-finger. J. Mol. Biol. 237:201-211.
5. Blondel, D., G. G. Harmison, and M. Schubert. 1990. Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J. Virol. 64:1716-1725.
6. Chebath, J., P. Benech, M. Revel, and M. Vigneron. 1987. Constitutive expression of (2′5′) oligo A synthetase confers resistance to picornavirus infection. Nature 330:587-588.
7. Chelbi-Alix, M. K., and S. Chousterman. 1992. Ethanol induces 2′5′ oligo-adenylate synthetase and antiviral activities through interferon β production. J. Biol. Chem. 267:1741-1745.
8. Chelbi-Alix, M. K., L. Pelicano, F. Quignon, M. H. M. Koken, L. Venturini, M. Stadler, J. Pavlovic, L. Degos, and H. de Thé. 1995. Induction of the PML protein by interferons in normal and APL cells. Leukemia 9:2027-2033.
9. Coccia, E. M., G. Romeo, A. Nissim, and G. Marziali. 1990. A full-length 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology 179:228-233.
10. Daniel, M.-T., M. Koken, O. Romagné, S. Barbey, A. Bazarbachi, M. Stadler, M. Guillemin, L. Degos, C. Chomienne, and H. de Thé. 1993. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82:1858-1867.
11. de Thé, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-684.
12. Dyck, J. A., G. G. Maul, W. H. Miller, J. D. Chen, A. Kakizuka, and R. M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333-343.
13. Emerson, S. U., and M. Schubert. 1987. Location of the binding domains for the RNA polymerase L and the ribonucleocapsid template within different halves of the NS phosphoprotein of vesicular stomatitis virus. Proc. Natl. Acad. Sci. USA 84:5655-5659.
14. Freemont, P., I. Hanson, and J. Trowsdale. 1991. A novel cysteine-rich sequence motif. Cell 64:483-484.
15. Freemont, P. S. 1993. The RING finger. A novel protein sequence motif related to the zinc finger. Ann. N.Y. Acad. Sci. 684:174-192.
16. Frese, M., G. Kochs, U. Meierdieter, J. Siebler, and O. Haller. 1995. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J. Virol. 69:3904-3909.
17. Gäken, J., F. Farzaneh, C. Stocking, and W. Osterlag. 1992. Construction of a versatile set of retroviral vectors confering hygromycin resistance. BioTechniques 13:32-33.
18. Guan, J.-L., C. E. Machamer, and J. K. Rose. 1985. Glycosylation allows cellsurface transport of an anchored secretory protein. Cell 42:489-496.
19. Guldner, H., C. Szostecki, T. Grotzinger, and H. Will. 1992. IFN enhances expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149:4067-4073.
20. Harlow, E., and D. Lane. Antibodies. A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
21. Kastner, P., A. Perez, Y. Lutz, C. Rochette-Egly, M.-P. Gaub, B. Durand, M. Lanotte, R. Berger, and P. Chambon. 1992. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11:629-642.
22. Koken, M. H. M., G. Linares-Cruz, F. Quignon, A. Viron, M. K. Chelbi-Alix, J. Sobczak-Thépot, L. Juhlin, L. Degos, F. Calvo, and H. de Thé. 1995. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315-1324.
23. Koken, M. H. M., F. Puvion-Dutilleul, M. C. Guillemin, A. Viron, G. Linares-Cruz, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne, L. Degos, E. Puvion, and H. de Thé. 1994. The t(15;17) translocation alters a nuclear body in a RA-reversible fashion. EMBO J. 13:1073-1083.
24. Lavau, C., A. Marchio, M. Fagioli, J. Jansen, B. Falini, P. Lebon, F. Grosveld, P. P. Pandolfi, P. G. Pelicci, and A. Dejean. 1995. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11:871-876.
25. Liu, J.-H., Z.-M. Mu, and K.-S. Chang. 1995. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J. Exp. Med. 181:1965-1973.
26. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral gene on two different plasmids. J. Virol. 62:1120-1124.
27. Meier, E., J. Fäh, M. S. Grob, R. End, P. Staeheli, and O. Haller. 1988. A family of interferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells. J. Virol. 62:2386-2393.
28. Meier, E., G. Kunz, O. Haller, and H. Arnheiter. 1990. Activity of rat Mx proteins against a rhabdovirus. J. Virol. 64:6263-6269.
29. Meurs, E., Y. Watanabe, S. Kadereit, G. Barber, M. Katze, K. Chong, B. Williams, and A. Hovanessian. 1992. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66:5805-5814.
30. Mu, Z. M., K. V. Chin, J. H. Liu, G. Lozano, and K. S. Chang. 1994. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14:6858-6867.
31. Pavlovic, J., T. Zurcher, O. Haller, and P. Staeheli. 1990. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64:3370-3375.
32. Perez, A., P. Kastner, S. Sethi, Y. Lutz, C. Reibel, and P. Chambon. 1993. PML/RAR homodimers: distinct binding properties and heteromeric interactions with RXR. EMBO J. 12:3171-3182.
33. Pitossi, F., A. Blank, A. Schröder, A. Schwarz, P. Hüssi, M. Schwemme, J. Pavlovic, and P. Staeheli. 1993. A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J. Virol. 67:6726-6732.
34. Puvion-Dutilleul, F., L. Venturini, M.-C. Guillemin, H. de Thé, and E. Puvion. 1995. Sequestration of PML and Sp100 proteins in an intranuclear viral structure during herpes simplex virus type 1 infection. Exp. Cell Res. 221:448-461.
35. Reddy, B., L. Etkin, and P. Freemont. 1992. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem. Sci. 17:344-345.
36. Rees, S., J. Coote, J. Stables, S. Goodson, S. Harris, and M. G. Lee. 1996. Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. BioTechniques 20:102-110.
37. Samuel, C. E. 1991. Antiviral-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1-11.
38. Schnorr, J. J., S. Schneider-Schaulies, A. Simon-Jödicke, J. Pavlovic, M. A. Horisberger, and V. Meulen. 1993. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J. Virol. 67:4760-4768.
39. Sen, G. C., and R. M. Ransohoff. 1993. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42:57-102.
40. Stadler, M., M. K. Chelbi-Alix, M. H. M. Koken, L. Venturini, C. Lee, A. Saïb, F. Quignon, L. Pelicano, M.-C. Guillemin, C. Schindler, and H. de Thé. 1995. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11:2565-2573.
41. Staeheli, P., F. Pitossi, and J. Pavlovic. 1993. Mx proteins: GTPases with antiviral activity. Trends Cell Biol. 3:268-272.
42. Stuurman, N., A. de Graaf, A. Floore, A. Josso, B. Humbel, L. de Jong, and R. van Driel. 1992. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J. Cell Sci. 101:773-784.
43. Szostecki, C., H. Guldner, H. Netter, and H. Will. 1990. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies of patients with primary biliary cirrhosis. J. Immunol. 145:4338-4347.
44. Warrell, R., H. de Thé, Z. Wang, and L. Degos. 1993. Acute promyelocytic leukemia. N. Engl. J. Med. 329:177-189.
45. Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localization of PML/RARα in acute promyelocytic leukemia cells. Cell 76: 345-356.
46. Zürcher, T., J. Pavlovic, and P. Staeheli. 1992. Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology 187:796-800.
47. Zürcher, T., J. Pavlovic, and P. Staeheli. 1992. Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus. J. Virol. 66:5059-5066.